# Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

> **NCT00288080** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 612 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Prednisone
- **DRUG:** docetaxel
- **DRUG:** Oral antiandrogen
- **RADIATION:** Radiation therapy
- **DRUG:** LHRH agonist

## Key facts

- **NCT ID:** NCT00288080
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2014-04
- **Final completion:** 2022-05-20
- **Target enrollment:** 612 (ACTUAL)
- **Last updated:** 2022-06-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288080, "Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00288080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*